Protocols
1 protocol(s) meet the specified criteria
Drug: BRENTUXIMAB VEDOTIN
Protocol No.TitleStatus
LCCC1115A Phase II Trial of Induction Chemotherapy with ABVD Followed by Brentuximab Vedotin (SGN-35) Consolidation in Patients with Previously Untreated Non-Bulky Stage I or II Hodgkin Lymphoma (HL)Open (affiliates only)